TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9521367

Group type: EXPERIMENTAL
Intervention: Dipstick urinalysis for UTI or hematuria
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Dipstick urinalysis for hematuria
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Overall management based on dipstick urinalysis
Number of subjects: 166
Study: 8024127

Group type: EXPERIMENTAL
Intervention: 0.1 minimum alveolar concentration isoflurane
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (carrier gas)
Number of subjects: 8
Study: 2478426

Group type: EXPERIMENTAL
Intervention: Starch (50 g) pudding meal (400 ml) with water (200 ml)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo with water (200 ml)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Amylase inhibitor (5 or 10 g) with water and starch
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Amylase inhibitor (4 g) with water and starch
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Amylase inhibitor (5 or 10 g)
Number of subjects: 14
Study: 796954

Group type: EXPERIMENTAL
Intervention: Intravenous ketoprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin (soluble form of acetylsalicylic acid)
Number of subjects: 0
Study: 31499228

Group type: EXPERIMENTAL
Intervention: Communication & Coping intervention (telephone and Facebook-delivered)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diabetes education control condition
Number of subjects: 0
Study: 28596023

Group type: EXPERIMENTAL
Intervention: Oligofructose-enriched inulin (OI; 8 g/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Maltodextrin placebo (isocaloric dose)
Number of subjects: 42
Study: 25939604

Group type: EXPERIMENTAL
Intervention: Circulating LCN2 levels above the median (76.6 ng/mL)
Number of subjects: 1009

Group type: EXPERIMENTAL
Intervention: Per standard deviation increase in LCN2
Number of subjects: 1009
Study: 23863583

Group type: EXPERIMENTAL
Intervention: Water group - patients drank 500 mL water after dinner on the evening before endoscopy, and 350 mL water before the examination.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group - patients drank nothing after dinner and nothing on the day of endoscopy.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Water group - specifically in patients with distal gastrectomy.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Water group - in patients who underwent proximal gastrectomy or pylorus-preserving gastrectomy.
Number of subjects: 0
Study: 21954526

Group type: EXPERIMENTAL
Intervention: 0.05 mg morphium hydrochloride (MCh)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.1 mg morphium hydrochloride (MCh)
Number of subjects: 40
Study: 19505307

Group type: EXPERIMENTAL
Intervention: Postmenopausal hormone therapy (HT)
Number of subjects: 1778

Group type: COMPARATOR
Intervention: Non-hormone therapy (non-HT)
Number of subjects: 1778
Study: 17014006

Group type: EXPERIMENTAL
Intervention: Abatacept 10 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abatacept 2 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12756979

Group type: EXPERIMENTAL
Intervention: Microencapsulated iron(II) fumarate sprinkles
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Microencapsulated iron(II) fumarate sprinkles with vitamin A
Number of subjects: 437

Group type: EXPERIMENTAL
Intervention: Iron(II) sulfate drops
Number of subjects: 437

Group type: COMPARATOR
Intervention: Placebo sprinkles
Number of subjects: 437

Group type: COMPARATOR
Intervention: No intervention (12 months post-supplementation)
Number of subjects: 437
Study: 11317165

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 13000
Study: 9316951

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 715

Group type: COMPARATOR
Intervention: Patient-controlled intravenous meperidine analgesia
Number of subjects: 715
Study: 8444328

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sodium Valproate
Number of subjects: 64

Group type: COMPARATOR
Intervention: Phenytoin
Number of subjects: 64
Study: 3742833

Group type: EXPERIMENTAL
Intervention: Melatonin (2 mg daily in 5 ml corn-oil)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (vehicle only)
Number of subjects: 12
Study: 30025470

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Air (sham)
Number of subjects: 0
Study: 27595996

Group type: EXPERIMENTAL
Intervention: Radiation oncology teaching (lectures, seminars, practices)
Number of subjects: 40
Study: 27028316

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 8.75 mg spray
Number of subjects: 505

Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 505
Study: 25064291

Group type: EXPERIMENTAL
Intervention: Electronic dietary recording system (EG)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Food diary (FD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 60
Study: 21881905

Group type: EXPERIMENTAL
Intervention: Light deprivation (LD)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Environmental light exposure (EL)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control subjects (CS)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Short‐interval intracortical inhibition and ratios between motor‐evoked potential amplitudes and supramaximal M responses
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Short-term variation of motor thresholds (MTs)
Number of subjects: 2
Study: 19066295

Group type: EXPERIMENTAL
Intervention: Recombinant human GH (0.5 mg every day) plus standardized diet and exercise program
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standardized diet and exercise program
Number of subjects: 24
Study: 17166305

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) at the globus pallidus internus (GPi)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) at the subthalamic nucleus (STN)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Left-sided deep brain stimulation (DBS)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Unilateral treatment
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Bilateral treatment
Number of subjects: 42
Study: 16327304

Group type: EXPERIMENTAL
Intervention: Ropivacaine (group I, n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine (group II, n = 30)
Number of subjects: 60
Study: 11890163

Group type: EXPERIMENTAL
Intervention: Orlistat combined with an energy and fat restricted diet
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo combined with an energy and fat restricted diet
Number of subjects: 12
Study: 9861119

Group type: EXPERIMENTAL
Intervention: Nimodipine 10 ml h‐1 (group N)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline (group C)
Number of subjects: 50
Study: 7714107

Group type: EXPERIMENTAL
Intervention: 3 x 10(6) IU iv IFN‐alpha 2
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1.5 mg Dex (1 mg at midnight the previous night and 0.5 mg at 0700 h on the day of the test) + 3 x 10(6) IU iv IFN‐alpha 2
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1.5 mg Dex (1 mg at midnight the previous night and 0.5 mg at 0700 h on the day of the test) + 2 mL iv saline
Number of subjects: 8

Group type: COMPARATOR
Intervention: 2 mL iv saline
Number of subjects: 8
Study: 2668037

Group type: EXPERIMENTAL
Intervention: Peri-operative blood transfusions
Number of subjects: 212

Group type: COMPARATOR
Intervention: No peri-operative blood transfusions
Number of subjects: 212
Study: 1259521

Group type: EXPERIMENTAL
Intervention: Phenothiazines (twice daily schedule)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Phenothiazines (after cessation)
Number of subjects: 27
Study: 29229058

Group type: EXPERIMENTAL
Intervention: Exercise therapy
Number of subjects: 122

Group type: COMPARATOR
Intervention: Qigong therapy
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 122
Study: 26205524

Group type: EXPERIMENTAL
Intervention: Arthrodesis plus Total Contact Casting (TCC)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Total Contact Casting (TCC)
Number of subjects: 21
Study: 23415543

Group type: EXPERIMENTAL
Intervention: Levodopa (L-DOPA) treatment
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 35
Study: 21812263

Group type: EXPERIMENTAL
Intervention: Astragalus Injection (2 mL/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 40
Study: 19442784

Group type: EXPERIMENTAL
Intervention: Doxycycline (DOX; 20 mg) twice a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Levonorgestrel-releasing subcutaneous implant (LNG SI)
Number of subjects: 0
Study: 16928840

Group type: EXPERIMENTAL
Intervention: Ethyl vinyl chloride vapocoolant spray
Number of subjects: 127

Group type: COMPARATOR
Intervention: Isopropyl alcohol spray (placebo)
Number of subjects: 127

Group type: COMPARATOR
Intervention: No spray (control)
Number of subjects: 127
Study: 15468351

Group type: EXPERIMENTAL
Intervention: Gold sodium thiomalate
Number of subjects: 41
Study: 11343405

Group type: EXPERIMENTAL
Intervention: Engaged in interactions and imagined others; memory test repeated 1 week later.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Activities where participant was the agent of action.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Object use during the activity.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Similarity among actions.
Number of subjects: 0
Study: 9460299

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 8186064

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide (200 micrograms three times daily)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Oxitropium bromide
Number of subjects: 56
Study: 3792086

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (100, 200, 600, or 1,200 micrograms)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 30462938

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (1×10^10 CFU twice daily for 5 days)
Number of subjects: 971

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 971

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG
Number of subjects: 971
Study: 27009465

Group type: EXPERIMENTAL
Intervention: DEAL Project (automated Web‐based self‐help intervention)
Number of subjects: 104

Group type: COMPARATOR
Intervention: HealthWatch (Web‐based attention-control condition)
Number of subjects: 104
Study: 25565480

Group type: EXPERIMENTAL
Intervention: Computer-based cognitive rehabilitation and right hemifield eye-patching
Number of subjects: 12

Group type: COMPARATOR
Intervention: Computer-based cognitive rehabilitation alone
Number of subjects: 12
Study: 23297772

Group type: EXPERIMENTAL
Intervention: Amoxicillin (AMX, 500 mg) + Metronidazole (MET, 250 mg), TID for 10 days
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 20492045

Group type: EXPERIMENTAL
Intervention: Chinese food therapy (specific dietary instructions, management of antihypertensive medication, brief health education)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Chinese food therapy
Number of subjects: 85

Group type: COMPARATOR
Intervention: Routine support (brief health education)
Number of subjects: 85
Study: 18672776

Group type: COMPARATOR
Intervention: Valaciclovir alone (Group B)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: QLM plus valaciclovir (Group C)
Number of subjects: 97
Study: 15905632

Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation (VNS) at three different stimulation intensities
Number of subjects: 10
Study: 12580992

Group type: EXPERIMENTAL
Intervention: Garlic supplements (10 mg of Natural Source Odourless Garlic)
Number of subjects: 10
Study: 10867376

Group type: EXPERIMENTAL
Intervention: Allergen specific immunotherapy with birch and/or timothy pollen allergen extract
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group receiving only pharmacotherapy
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: D. Pteronyssinus immunotherapy
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control group receiving medication only
Number of subjects: 210
Study: 8889739

Group type: EXPERIMENTAL
Intervention: Exercise at 60% VO2max
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Exercise at 75% VO2max
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Exercise at 30% VO2max
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Exercise at 45% VO2max
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Exercise at 30% and 45% VO2max
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Exercise at lower intensities (30% and 45% VO2max)
Number of subjects: 5
Study: 2070239

Group type: EXPERIMENTAL
Intervention: Lateral paramedian incision with layered closure
Number of subjects: 349

Group type: COMPARATOR
Intervention: Midline incision with mass closure
Number of subjects: 349

Group type: COMPARATOR
Intervention: Midline incision with layered closure
Number of subjects: 349
Study: 6685418

Group type: EXPERIMENTAL
Intervention: Hormonal treatment for mastopathy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-hormonal treatment for mastopathy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conservative treatment of mastopathy
Number of subjects: 0
Study: 31372649

Group type: EXPERIMENTAL
Intervention: Referral letters
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Response letters
Number of subjects: 100
Study: 30955869

Group type: EXPERIMENTAL
Intervention: Everolimus (after conversion from cyclosporine)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Epitope load greater than 27
Number of subjects: 89

Group type: COMPARATOR
Intervention: HLA mismatches
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Epitope load threshold of 27
Number of subjects: 89
Study: 26522915

Group type: EXPERIMENTAL
Intervention: SnFl-Zn mouthwash
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: alcohol-free EO mouthwash
Number of subjects: 20

Group type: COMPARATOR
Intervention: CHX mouthwash
Number of subjects: 20
Study: 26768126

Group type: EXPERIMENTAL
Intervention: Subcutaneous (s.c.) TBE vaccination
Number of subjects: 116

Group type: COMPARATOR
Intervention: Intramuscular (i.m.) TBE vaccination
Number of subjects: 116
Study: 25151646

Group type: EXPERIMENTAL
Intervention: HeadStrong
Number of subjects: 380

Group type: COMPARATOR
Intervention: Personal Development, Health and Physical Education (PDHPE)
Number of subjects: 380
Study: 22483860

Group type: EXPERIMENTAL
Intervention: Plasma Rich in Growth Factor Plasma (PRGF)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Control group (no PRGF treatment)
Number of subjects: 176
Study: 20618356

Group type: EXPERIMENTAL
Intervention: Adrenaline infusion (0.1 nmol kg⁻¹ min⁻¹)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 8
Study: 17627239

Group type: EXPERIMENTAL
Intervention: Laparoscopic nephrectomy
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Laparoscopic nephrectomy (after excluding reoperated/converted donors)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Open nephrectomy
Number of subjects: 122
Study: 15787942

Group type: EXPERIMENTAL
Intervention: Alosetron
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 15922478

Group type: EXPERIMENTAL
Intervention: 25 mg emtricitabine once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 100 mg emtricitabine once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 200 mg emtricitabine once daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 200 mg emtricitabine open-label after 48 weeks
Number of subjects: 0
Study: 10370678

Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy with doxorubicin 50 mg/m2
Number of subjects: 72

Group type: COMPARATOR
Intervention: Systemic chemotherapy with doxorubicin 50 mg/m2
Number of subjects: 72
Study: 8677192

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) secretion in patients with ARSD under water immersion (IW)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Water, Na, Ca, Mg, and oxalic acid excretion in patients with ARSD under water immersion (IW)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Correlation between serum ANP levels and urinary excretion of Na, Ca, and Mg in patients with ARSD
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Correlation between serum ANP levels and urinary excretion of oxalic acid in patients with ARSD during water immersion (IW)
Number of subjects: 30
Study: 1854252

Group type: EXPERIMENTAL
Intervention: IL-2 alone
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: IL-2 plus lymphokine-activated killer cells
Number of subjects: 43

Group type: COMPARATOR
Intervention: IL-2 alone and IL-2 plus lymphokine-activated killer cells
Number of subjects: 43
Study: 6626018

Group type: EXPERIMENTAL
Intervention: Topical 1% aqueous suspension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical 1% oil suspension
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral indomethacin
Number of subjects: 0
Study: 31477160

Group type: EXPERIMENTAL
Intervention: TRIUMPH intervention (standardised LUTS advice booklet delivered by nurses/healthcare assistants with follow-up contacts over 12 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care pathway
Number of subjects: 30
Study: 28482106

Group type: EXPERIMENTAL
Intervention: Structured Physical Activity (PA)
Number of subjects: 1635

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 1635
Study: 26209003

Group type: EXPERIMENTAL
Intervention: Loop diuretics (40 mg furosemide equivalents)
Number of subjects: 475
Study: 25194668

Group type: EXPERIMENTAL
Intervention: Aluminum-containing deodorant and soap
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Non-aluminum containing deodorant and soap
Number of subjects: 333

Group type: COMPARATOR
Intervention: Soap (control)
Number of subjects: 333
Study: 22421631

Group type: EXPERIMENTAL
Intervention: Nebivolol (10-40 mg/day, titrated based on BP response)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 207
Study: 20600557

Group type: EXPERIMENTAL
Intervention: 225 ppm NaF
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 1450 ppm NaF
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 5000 ppm NaF
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 19000 ppm NaF
Number of subjects: 50

Group type: COMPARATOR
Intervention: Distilled water control
Number of subjects: 50
Study: 17905046

Group type: EXPERIMENTAL
Intervention: Parents of burn victims
Number of subjects: 273
Study: 15629969

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 44

Group type: COMPARATOR
Intervention: Routine Care
Number of subjects: 44
Study: 12242072

Group type: EXPERIMENTAL
Intervention: Group AGG (serial external electrical cardioversion)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Group CTL (non-treatment of atrial fibrillation relapse)
Number of subjects: 90
Study: 10354031

Group type: EXPERIMENTAL
Intervention: Humoristic leaflet (H‐leaflet)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Alarmist leaflet (A‐leaflet)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Neutral information leaflet (N‐leaflet)
Number of subjects: 300

Group type: COMPARATOR
Intervention: No leaflet (Control)
Number of subjects: 300
Study: 7486182

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Alfentanil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 30
Study: 30527630

Group type: EXPERIMENTAL
Intervention: Proximal cannula placement (within 1cm of the right hepatic vein orifice)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Distal cannula placement (within 1cm of the right hepatic vein orifice)
Number of subjects: 32
Study: 28704126

Group type: EXPERIMENTAL
Intervention: Adalimumab (ADA) treatment
Number of subjects: 1196
Study: 27228433

Group type: EXPERIMENTAL
Intervention: Higher visit-to-visit systolic blood pressure variability (SBPV)
Number of subjects: 4745

Group type: EXPERIMENTAL
Intervention: Visit-to-visit diastolic blood pressure variability (DBPV)
Number of subjects: 4745
Study: 24533697

Group type: EXPERIMENTAL
Intervention: Pasireotide 600/900 μg bid
Number of subjects: 162
Study: 22145743

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Oral hygiene educational programs
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Gender (female)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Frequency of oral hygiene behaviour at 3 months
Number of subjects: 113
Study: 21105556

Group type: EXPERIMENTAL
Intervention: ECG with pre-selected abnormalities
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Chest X-ray with cardio-thoracic ratio > 0.5
Number of subjects: 35

Group type: COMPARATOR
Intervention: Echocardiography
Number of subjects: 35

Group type: COMPARATOR
Intervention: ECG
Number of subjects: 35

Group type: COMPARATOR
Intervention: Chest X-ray
Number of subjects: 35
Study: 17551129

Group type: EXPERIMENTAL
Intervention: 1 mg/d of folic acid
Number of subjects: 1021

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1021
Study: 15198752

Group type: EXPERIMENTAL
Intervention: Cognitive-behaviour therapy intervention program (6 sessions between weeks 2 and 6 after birth)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Overall (both groups)
Number of subjects: 199
Study: 11480595

Group type: EXPERIMENTAL
Intervention: New Charnley instrumentation
Number of subjects: 123

Group type: COMPARATOR
Intervention: Original method
Number of subjects: 123
Study: 9494705

Group type: EXPERIMENTAL
Intervention: Tryptophan depletion methodology
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lithium treatment
Number of subjects: 0
Study: 8974346

Group type: EXPERIMENTAL
Intervention: Intra-muscular thiamin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0